Assessment of greenhouse gas emission of type 2 diabetes management in adults: a modelling study in the UK

Read full text
Authors: Niels Lund, Ekaterina Maslova, Jieling Chen, Julia Giannini, Mar Bawai Soro, Ian Culligan, Glyn Richards, Loveleen Taneja, Shanky Varghese, Yuxin Li, Weiwei Xu, Jose Gonzalez
+5 more Joice Valentim, Priscille de La Tour, Fiona Adshead, Keith M. Moore, Anna Puggina
Cited by: 1
References: 36

Abstract

Background The carbon footprint of end-to-end healthcare deliveries by the National Health Service in England totalled 25.0 megatons of carbon dioxide equivalent (CO 2 e) in 2019. Optimal and sustainable healthcare can lead to better health outcomes as well as a lower environmental footprint. Objectives To evaluate the potential impact of prevention and effective management of type 2 diabetes mellitus (T2DM) in adults on both the clinical outcomes and greenhouse gas (GHG) emissions in the UK healthcare setting. Research design and methods We incorporated an environmental module into the existing IQVIA core diabetes model to estimate the impact of improving clinical outcomes on GHG emissions over a lifetime horizon. We assessed two hypothetical scenarios: (1) preventing progression from pre-diabetes to T2DM through diet and exercise versus no intervention and natural disease progression to T2DM; and (2) well-controlled T2DM using interventions with clinical benefit on glycosylated haemoglobin (HbA1c), and renal and cardiovascular outcomes versus uncontrolled T2DM. Results Preventing progression to T2DM led to 6.357 additional undiscounted life years and 67% less kg CO 2 e emissions compared with subsequent natural progression to T2DM for a person with pre-diabetes over a lifetime (emissions of 9586 kg CO 2 e over 37.115 years vs 28 716 kg CO 2 e over 30.758 years, respectively). Well-controlled T2DM led to 1.947 additional undiscounted life years and 21% less kg CO 2 e emissions per patient over a lifetime compared with uncontrolled T2DM (emissions of 14 545 kg CO 2 e over 22.772 years vs 18 516 kg CO 2 e over 20.825 years, respectively). In both scenarios, the GHG emission savings were primarily due to reduced emissions related to avoidance of treating complications of T2DM including cardiovascular, renal and eye diseases. Conclusion Effective prevention and management of T2DM through implementation of evidence-based clinical guidelines can improve patient outcomes while reducing the healthcare-related environmental impacts.

Fields of Study & Subjects

Climate Change and Health Impacts Agriculture Sustainability and Environmental Impact Health Environment Cognitive Aging

Publication details

Journal / source
BMJ Open
Publisher
BMJ
Volume
16
Issue
1
Pages
e106299–e106299
Publication date
1 January 2026
Language
EN